DrugPatentWatch Database Preview
QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE Drug Profile
» See Plans and Pricing
When do Quinapril Hydrochloride And Hydrochlorothiazide patents expire, and when can generic versions of Quinapril Hydrochloride And Hydrochlorothiazide launch?
Quinapril Hydrochloride And Hydrochlorothiazide is a drug marketed by Apotex Corp, Aurobindo Pharma, Invagen Pharms, Mylan, and Sun Pharm Inds Ltd. and is included in five NDAs.
The generic ingredient in QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE is hydrochlorothiazide; quinapril hydrochloride. There are thirty-two drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the hydrochlorothiazide; quinapril hydrochloride profile page.
Summary for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Suppliers / Packagers: | 3 |
| Clinical Trials: | 7 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| LaborMed Pharma S.A. | Phase 4 |
| National Center for Research Resources (NCRR) | Phase 4 |
| Vanderbilt University Medical Center | Phase 4 |
See all QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE clinical trials
Pharmacology for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
| Drug Class | Angiotensin Converting Enzyme Inhibitor Thiazide Diuretic |
| Mechanism of Action | Angiotensin-converting Enzyme Inhibitors |
| Physiological Effect | Increased Diuresis |
US Patents and Regulatory Information for QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex Corp | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; quinapril hydrochloride | TABLET;ORAL | 091524-001 | Mar 12, 2013 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Invagen Pharms | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; quinapril hydrochloride | TABLET;ORAL | 201356-001 | Apr 20, 2011 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Aurobindo Pharma | QUINAPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | hydrochlorothiazide; quinapril hydrochloride | TABLET;ORAL | 078450-001 | Aug 24, 2007 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
